RNAC Operating Income Growth
Cartesian Therapeutics Inc · Operating Income Growth
RNAC Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-33.67%period ending
RNAC Quarterly Operating Income YoY % (-19.47% → -33.67%)
Year-over-year change
High-resolution chart · PNG
RNAC operating income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Income Growth |
|---|---|
| -33.6711% | |
| -21.0608% | |
| 17.9268% | |
| -19.8634% | |
| -258.5447% | |
| -63.9871% | |
| 26.4257% | |
| -34.5197% | |
| 173.8116% | |
| 27.3815% | |
| -327.6365% | |
| -717.0732% | |
| -234.4733% | |
| -270.621% | |
| -308.3374% | |
| 18.7913% | |
| 2,966.3717% | |
| 250.5029% | |
| 151.6333% | |
| 85.6633% | |
| 102.7617% | |
| 61.97% | |
| 37.1679% | |
| -16.449% | |
| -0.8131% | |
| -58.7551% | |
| 13.3044% | |
| 26.0147% | |
| 13.501% | |
| 25.0237% | |
| 24.786% | |
| -15.0642% | |
| -18.2597% | |
| -6.9747% | |
| -39.0837% | |
| -85.5115% | |
| -147.9456% | |
| -112.9664% | |
| -95.019% | |
| -23.011% | |
| -1.3458% | |
| -19.4664% |